Aurelius Health Group review
Candid, narrow, bundled
A tirzepatide microdosing practice with fully published all-in pricing, offering NAD⁺ as an add-on — and unusually honest about its own thin evidence.
Our verdict
Aurelius does something almost nobody in this category does: it tells you, on its own website, that large-scale trial data at sub-therapeutic doses is limited. Combined with fully published all-in pricing and a bundled care model, that candour earns real credit. The caveats are structural — the whole practice is built on a single microdose protocol, NAD⁺ is only an add-on with no separate published price, and no state list, pharmacy or medical director is disclosed.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- NAD⁺ telehealth
- Access
- Microdose protocol $89 first month, then $199/mo; NAD⁺ priced as an add-on
- Insurance
- Cash-pay, no insurance
- LegitScript
- Certified
- Updated
- July 2026
Popular alternative
Enhance MD
Physician-supervised NAD⁺ under lab-guided oversight
Check Enhance MD availability →What it is
Aurelius Health Group is a telehealth practice built around a compounded tirzepatide microdosing protocol — a low-dose dual GIP/GLP-1 approach rather than standard full-dose therapy — with NAD⁺, L-carnitine, B-12 and inositol offered as optional add-ons. It is the microdose protocol, not the NAD⁺, that is the product; the NAD⁺ is an accessory to it. Pricing is published in full and the subscription covers physician consultations, the protocol itself, shipping and ongoing monitoring.
How it works
Care-inclusive rather than prescription-only, which is the model's genuine strength: the monthly price covers an initial consultation with a board-certified MD or DO, a 24-hour prescription review, pharmacy shipment, monthly physician check-ins with protocol adjustments, and secure messaging on a HIPAA platform. Monthly clinician contact built into the price is a meaningfully better structure than an automated refill. Cancellation is stated as available anytime before the next billing cycle with no hidden fees. What is not disclosed sits on the other side of the ledger and is not trivial: no legal entity, no state list, no named compounding pharmacy, no named medical director or pharmacist-in-charge, and while a LegitScript seal is displayed, the certification ID number is not surfaced for lookup.
Pricing transparency
Aurelius publishes its pricing openly — $89 for the first month and $199 per month thereafter — and that figure is bundled, covering consultations, the protocol, shipping and monitoring. Published, bundled pricing is meaningfully more transparent than most compounded brands manage, and it is the strongest thing on this card. One clarification matters for this board: that price is the tirzepatide microdose protocol, not an NAD⁺ price. The NAD⁺ add-on cost is not broken out, so ask what it adds monthly, what dose and route it covers, and whether it is billed inside the subscription or separately before assuming the published figure covers it.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The tirzepatide is compounded by licensed US compounding pharmacies — none named — and is not brand-name Mounjaro or Zepbound, nor therapeutically equivalent to either. Two evidence points, and Aurelius is unusually straight about the first. Microdosing: sub-therapeutic dosing has a thinner trial base than full-dose therapy and should be expected to produce smaller results, which the company itself flags rather than obscures. The NAD⁺ add-on: injectable NAD⁺ has no controlled human outcome trials supporting the energy or longevity claims the category is sold on, and the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly. The NAD⁺ evidence that exists is with the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a biomarker, not an outcome. Stacking an unproven add-on onto a deliberately reduced dose is worth thinking about carefully rather than treating as a bonus. Individual results vary.
Pros and watch-outs
What we like
- Pricing published in full and bundled: $89 first month, then $199/mo all-in
- Care-inclusive — consultations, monthly physician check-ins and monitoring, not just a refill
- Unusually candid on its own site about the limited evidence for microdosing
- LegitScript certified seal displayed
- Cancel anytime before the next billing cycle, with no hidden fees
Watch-outs
- NAD⁺ is an add-on with no separately published price
- Injectable NAD⁺ has no controlled human outcome trials
- Microdose-only model — no full-dose or semaglutide option
- No named compounding pharmacy, medical director or pharmacist-in-charge
- No state list published, and the LegitScript ID is not surfaced for lookup
Best for
People who want a transparently priced, clinician-monitored tirzepatide microdose protocol and are considering NAD⁺ as a secondary add-on to it.
Who should look elsewhere
Anyone shopping for NAD⁺ as the primary treatment, wanting full-dose GLP-1 therapy, or needing a named pharmacy and a published state list.
The evidence behind what Aurelius Health Group prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
How Aurelius Health Group compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Tru Niagen
The most clinically-studied oral NAD⁺ precursor (NR)
See Tru Niagen → - Renue By Science
Liposomal/sublingual NMN with posted lab testing
See Renue By Science → 
Invigor MedicalPrescription at-home NAD⁺ injections via telehealth
See Invigor Medical →
Peptides & longevity · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Aurelius Health Group’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is Aurelius an NAD⁺ provider?
- Only as an add-on. The product is a compounded tirzepatide microdose protocol; NAD⁺, L-carnitine, B-12 and inositol are optional additions to it. If NAD⁺ is your primary goal, this practice is built around something else, and the NAD⁺ price is not published separately.
- What does Aurelius cost?
- It publishes $89 for the first month and $199 per month thereafter, bundled to cover physician consultations, the protocol, shipping and ongoing monitoring. That is the microdose protocol price — ask what the NAD⁺ add-on adds monthly, what dose and route it covers, and whether it is billed inside the subscription.
- Does GLP-1 microdosing work as well as full-dose therapy?
- It should not be expected to. Sub-therapeutic dosing has a much thinner trial base and smaller expected effect than the full doses used in the pivotal trials. Aurelius says so itself on its own site, which is more honest than most of this category manages, and that candour is a reason to trust the operator rather than the protocol.
- What does Aurelius not disclose?
- Its legal entity, the states it serves, its compounding pharmacy, and a named medical director or pharmacist-in-charge. A LegitScript seal is displayed but the certification ID is not surfaced, so you cannot independently look it up. Those are reasonable things to ask for before enrolling.